NO20070635L - Faste former av magnesiumsalt av S-omeprazol og fremgangsmater for deres fremstilling - Google Patents

Faste former av magnesiumsalt av S-omeprazol og fremgangsmater for deres fremstilling

Info

Publication number
NO20070635L
NO20070635L NO20070635A NO20070635A NO20070635L NO 20070635 L NO20070635 L NO 20070635L NO 20070635 A NO20070635 A NO 20070635A NO 20070635 A NO20070635 A NO 20070635A NO 20070635 L NO20070635 L NO 20070635L
Authority
NO
Norway
Prior art keywords
omeprazole
magnesium salt
solid forms
solvent
processes
Prior art date
Application number
NO20070635A
Other languages
English (en)
Norwegian (no)
Inventor
Ramon Berenguer Maimo
Laura Coppi
Yolanda Gasanz Guillen
Jorge Medrano Ruperez
Original Assignee
Esteve Quimica Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Quimica Sa filed Critical Esteve Quimica Sa
Publication of NO20070635L publication Critical patent/NO20070635L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20070635A 2004-07-02 2007-02-02 Faste former av magnesiumsalt av S-omeprazol og fremgangsmater for deres fremstilling NO20070635L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200401729A ES2246149B1 (es) 2004-07-02 2004-07-02 Formas solidas de la sal magnesica de s-omeprazol y procedimientos para su preparacion.
PCT/EP2005/053062 WO2006003163A1 (en) 2004-07-02 2005-06-29 Solid forms of the magnesium salt of (s)-omeprazole and processes for their preparation

Publications (1)

Publication Number Publication Date
NO20070635L true NO20070635L (no) 2007-03-20

Family

ID=34972307

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20070635A NO20070635L (no) 2004-07-02 2007-02-02 Faste former av magnesiumsalt av S-omeprazol og fremgangsmater for deres fremstilling

Country Status (19)

Country Link
US (1) US7902370B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP1765807B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (2) JP5575366B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR101290035B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN1976923B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE425975T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU2005259205B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2570559C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CY (1) CY1109048T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE602005013382D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK1765807T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (2) ES2246149B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HR (1) HRP20090211T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MXPA06014736A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO20070635L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ552458A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT1765807E (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO2006003163A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA200700865B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2246149B1 (es) * 2004-07-02 2007-06-01 Esteve Quimica, S.A. Formas solidas de la sal magnesica de s-omeprazol y procedimientos para su preparacion.
FR2920428B1 (fr) * 2007-08-29 2012-06-15 Univ Rouen Procede de dedoublement de sels de l'omeprazole
EP2147918A1 (en) 2008-07-21 2010-01-27 LEK Pharmaceuticals D.D. Process for the preparation of S-omeprazole magnesium in a stable form
CN103044400A (zh) * 2012-12-21 2013-04-17 北京华禧联合科技发展有限公司 埃索美拉唑镁盐及其制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302396D0 (sv) * 1993-07-09 1993-07-09 Ab Astra A novel compound form
HUT75775A (en) * 1994-07-08 1997-05-28 Astra Ab Medicament with multiple unit tablated dosage form containing omeprazole
SE508669C2 (sv) * 1996-04-26 1998-10-26 Astra Ab Nytt förfarande
SE510666C2 (sv) * 1996-12-20 1999-06-14 Astra Ab Nya Kristallmodifikationer
SE510650C2 (sv) * 1997-05-30 1999-06-14 Astra Ab Ny förening
US6326384B1 (en) * 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
SI20974A (sl) * 1999-08-26 2003-02-28 Aaipharma, Inc. Alkoksi substituirane benzimidazolne spojine, farmacevtski pripravki, ki jih vsebujejo ter metode za njihovo uporabo
US6312712B1 (en) * 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
CN1437593A (zh) 2000-05-15 2003-08-20 兰贝克赛实验室有限公司 新颖的无定形奥美拉唑盐
CA2386716C (en) * 2002-05-17 2012-07-24 Bernard Charles Sherman Magnesium salt of s-omeprazole
CA2775616C (en) * 2000-08-04 2013-09-17 Takeda Pharmaceutical Company Limited Salts of benzimidazole compound and application thereof
SI20875A (sl) * 2001-04-25 2002-10-31 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Kristalna oblika omeprazola
WO2003089408A2 (en) * 2002-04-22 2003-10-30 Sun Pharmaceutical Industries Limited Optically active substituted pyridinylmethyl-sulphinyl-benzimidazole and salts
US6894066B2 (en) * 2002-05-09 2005-05-17 Bernard Charles Sherman Magnesium salt of S-omeprazole
US7612098B2 (en) * 2002-08-30 2009-11-03 Dr. Reddy's Laboratories Limited Amorphous hydrous esomeprazole magnesium
CN1728997A (zh) * 2002-10-22 2006-02-01 兰贝克赛实验室有限公司 (es)奥美拉唑的无定形盐
WO2004046134A2 (en) * 2002-11-18 2004-06-03 Dr. Reddy's Laboratories Limited Crystalline form ii of esomeprazole magnesium trihydrate and process for its preparation
WO2004089935A1 (en) * 2003-04-10 2004-10-21 Hetero Drugs Limitd Novel crystalline forms of s-omeprazole magnesium
ES2246149B1 (es) * 2004-07-02 2007-06-01 Esteve Quimica, S.A. Formas solidas de la sal magnesica de s-omeprazol y procedimientos para su preparacion.

Also Published As

Publication number Publication date
ES2246149B1 (es) 2007-06-01
EP1765807B1 (en) 2009-03-18
CA2570559A1 (en) 2006-01-12
US7902370B2 (en) 2011-03-08
NZ552458A (en) 2010-07-30
MXPA06014736A (es) 2007-06-25
KR101290035B1 (ko) 2013-07-30
DK1765807T3 (da) 2009-06-08
JP2014169302A (ja) 2014-09-18
CN1976923B (zh) 2011-08-24
CN1976923A (zh) 2007-06-06
JP2008505160A (ja) 2008-02-21
WO2006003163A1 (en) 2006-01-12
AU2005259205B2 (en) 2011-01-27
DE602005013382D1 (de) 2009-04-30
US20070249684A1 (en) 2007-10-25
ZA200700865B (en) 2009-09-30
KR20070031992A (ko) 2007-03-20
AU2005259205A1 (en) 2006-01-12
CA2570559C (en) 2012-08-28
ATE425975T1 (de) 2009-04-15
CY1109048T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2014-07-02
HRP20090211T1 (en) 2009-05-31
PT1765807E (pt) 2009-04-13
ES2323319T3 (es) 2009-07-13
EP1765807A1 (en) 2007-03-28
ES2246149A1 (es) 2006-02-01
JP5575366B2 (ja) 2014-08-20

Similar Documents

Publication Publication Date Title
JP2006515829A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO20075707L (no) Syntese av bis(tio-hydrazid-amid)salter
RU2009119515A (ru) Способ получения сукралозы хлорированием сахара трифосгеном (втс)
NO20070635L (no) Faste former av magnesiumsalt av S-omeprazol og fremgangsmater for deres fremstilling
EP4178956A2 (en) Improved method for the production of lysergic acid diethylamide (lsd) and novel derivatives thereof
TW201022276A (en) Process for the preparation of (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl(1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamate
CN101730690A (zh) 磺酰胺化合物及其结晶
JP2016531925A (ja) ペメトレキセド製造のための中間体製造方法及びこれを用いて高純度ペメトレキセドを製造する方法
JP2011511053A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP4967659B2 (ja) L−カルニチンの精製方法
TW201245114A (en) Process for the preparation of pyrazole carboxylic acid amides
CN109485596A (zh) 一种含吲哚啉的登革病毒抑制剂的制备方法
CN110804022B (zh) 一种右丙亚胺的制备方法
CN109705010B (zh) 一种高纯度赖诺普利的制备工艺
CN108129357B (zh) 阿拉莫林中间体的制备方法
CN103896951A (zh) 2-甲基-吡唑并[1,5-a]嘧啶-6-羧酸的合成方法
CN111481546A (zh) 娃儿藤生物碱或其盐在抗冠状病毒上的应用
CN100546969C (zh) 拆分2-羟甲基-3-苯基丙酸光学异构体的方法
KR20160061542A (ko) 새로운 루리코나졸 이성체 분리 방법
US12145910B2 (en) Method for synthesizing 3-spiro three-membered ring indolinone derivative
KR102658673B1 (ko) (1r,3s)-3-아미노기-1-사이클로펜탄올 및 그 염의 제조방법
CN109096047B (zh) 一种(1r)-1,3-二苯基-1-丙醇的制备方法
CN104829513B (zh) 一种2-羧基-4-甲氧基甲基吡咯烷衍生物的制备方法
US8877947B2 (en) Process for preparation of substantially pure fosamprenavir calcium and its intermediates
CN102659619A (zh) 一种合成酪氨酸衍生物的方法

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application